Showing results (1801-1810 of 1,828) with videos related to

Sort By:
Pageof 183
Nature Communications|November 10, 2024
Base-editing corrects metabolic abnormalities in a humanized mouse model for glycogen storage disease type-IaIrina Arnaoutova, Yvonne Aratyn-Schaus, Lisa Zhang, et al.
Drug Design, Development and Therapy|May 21, 2026
Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III StudyJong-Chan Youn, So-Young Lee, Cheol Woong Yu, et al.
Journal of Pathology and Translational Medicine|November 20, 2025
Diagnostic value of cytology in detecting human papillomavirus-independent cervical malignancies: a nation-wide study in KoreaHye-Ra Jung, Junyoung Shin, Chong Woo Yoo, et al.
Clinical Therapeutics|February 10, 2016
Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical StudyHan Cheol Lee, Sang-Rok Lee, Kyoo-Rok Han, et al.
Cancers|July 24, 2021
Nuclear HKII-P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian CancerChae Young Han, David A Patten, Se Ik Kim, et al.
The Korean Journal of Internal Medicine|November 28, 2017
The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 studyJae Ho Byun, Joong Bae Ahn, Sun Young Kim, et al.
Yonsei Medical Journal|November 20, 2018
The Brain Donation Program in South KoreaYeshin Kim, Yeon Lim Suh, Seung Joo Kim, et al.
Translational Lung Cancer Research|February 9, 2026
Clinical implications of plasma EGFR T790M and ctDNA shedding across metastatic sites in plasma- or tissue-confirmed EGFR-mutant non-small cell lung cancer treated with lazertinib: a prospective multicenter cohort studyMin Jee Kim, Junghee Jung, Wonjun Ji, et al.
Cancer Research|January 14, 2017
Superior Efficacy and Selectivity of Novel Small-Molecule Kinase Inhibitors of T790M-Mutant EGFR in Preclinical Models of Lung CancerJin Kyung Rho, In Yong Lee, Yun Jung Choi, et al.
Nature Cancer|June 12, 2023
Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerChanghwan Sung, Jinhyeon An, Soohyeon Lee, et al.
Pageof 183